These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Levamisole as an immunopotentiator for T cell deficiency. Taki HN; Schwartz SA Immunopharmacol Immunotoxicol; 1994 May; 16(2):129-37. PubMed ID: 8077602 [TBL] [Abstract][Full Text] [Related]
5. Levamisole therapy for cellular immunologic deficiency with high IgE values. Vanheule R; De Cree J; Adriaenssens K; De Hauwere R Acta Paediatr Belg; 1976; 29(1):41-6. PubMed ID: 1015292 [No Abstract] [Full Text] [Related]
6. [Immunostimulation in the treatment of decreased immunity]. SarosieK J; Górska M; Bogdanikowa B; Waszkiel B; Jodczyk J Pol Tyg Lek; 1980 Jun; 35(23):877-8. PubMed ID: 7413510 [No Abstract] [Full Text] [Related]
8. [Nature of the disturbance of immune protection in diabetes mellitus and its correction with levamisole]. Potemkin VV; Apanas'eva SN Probl Endokrinol (Mosk); 1982; 28(1):17-21. PubMed ID: 6977769 [TBL] [Abstract][Full Text] [Related]
9. [Levamisole in the combined treatment of patients with ischemic heart disease]. Gorb GD; Makovskaia TE; Tsybul'nik ZI; Grushko IV; Eremeev VS Vrach Delo; 1988 Aug; (8):38-40. PubMed ID: 3264642 [No Abstract] [Full Text] [Related]
10. Reactivating effect of levamisole on cell-mediated immunity in gastrointestinal cancer patients. Miwa H; Orita K Acta Med Okayama; 1977 Oct; 31(5):325-9. PubMed ID: 146404 [TBL] [Abstract][Full Text] [Related]
11. [Akne conglobata with immunodeficiency and its Levamisol treatment (author's transl)]. Westphal HJ; Schütt C; Kaben U; Mattheus A Dermatol Monatsschr; 1981 Jul; 167(7):410-7. PubMed ID: 6456159 [No Abstract] [Full Text] [Related]
12. II. In vitro restoration by levamisole of mitogen responsiveness in zinc-deprived rats. Gross RL; Osdin N; Fong L; Newberne PM Am J Clin Nutr; 1979 Jun; 32(6):1267-71. PubMed ID: 443189 [TBL] [Abstract][Full Text] [Related]
13. [Clinico-immunologic evaluation of the effect of decaris (levamisole) in chronic lymphoid leukemia]. Streneva TN; Shalaev VA; Krylova IV Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):20-3. PubMed ID: 6983689 [No Abstract] [Full Text] [Related]
14. [Levamisol and cell-mediated immunity in sarcoidosis (author's transl)]. Votova V; Haskovcová H; Strejcek J Z Erkr Atmungsorgane; 1977 Aug; 149(2):207-11. PubMed ID: 610098 [TBL] [Abstract][Full Text] [Related]
15. [Immunosuppression of burn patients. Treatment with levamisole]. Renoux G; Renoux M; Greco JM Ann Chir Plast; 1979; 24(1):57-9. PubMed ID: 317422 [No Abstract] [Full Text] [Related]
16. Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro. Lichtenfeld JL; Desner MR; Wiernik PH; Mardiney MR Cancer Treat Rep; 1976 May; 60(5):571-4. PubMed ID: 991144 [TBL] [Abstract][Full Text] [Related]
17. The effect of levamisole on gingival inflammation in man. Ivanyi L; Lehner T Scand J Immunol; 1977; 6(3):219-26. PubMed ID: 322263 [TBL] [Abstract][Full Text] [Related]
18. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy. Urist MM; Boddie AW; Townsend CM; Holmes EC J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)]. Sakharchuk II; Skakal'skaia LM Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185 [No Abstract] [Full Text] [Related]
20. [Levamisole, a chemically defined substance with immunostimulating potential--a review]. Staber GF Fortschr Med; 1976 May; 94(14):793-800. PubMed ID: 5347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]